A recent Dutch study that compared different detoxification techniques has found that anaesthetising patients during accelerated opiate withdrawal does not help patients complete the detox or sustain drug use reductions.
read more
Two European studies have confirmed that the opiateblocking
drug naltrexone particularly helps alcohol-dependent
patients who respond least well to therapy.
read more
The results of a recent Australian study comparing the safety and efficacy of a single-treatment sustained-release naltrexone implant with daily oral naltrexone treatment.
read more
The results of the first randomised trial of naltrexone implants carried out by staff at inpatient drug clinics in Norway.
read more
This very current (2008) study reviews therapeutic naltrexone blood levels using different strength implants.
read more
In 2005, Detox 5 were invited to work with a researcher from the University of Sheffield to look at the impact of heroin use and withdrawal on some elements of eyesight.
read more
In this study, Detox 5 collaborated with the University of Keele and some American researchers to look at the ways in which opiate users also used other medication to help them sleep.
read more
An editorial for the September 2003 edition of Addiction Biology.
read more
This is the first peer reviewed research paper produced by Detox 5 and looks at the treatment and outcomes to both physical well being and opiate use over a period of twelve months following treatment.
read more